{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T16:50:37Z","timestamp":1725555037066},"reference-count":44,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objective: To review the pathological diagnosis of possible cases and\/or hidden cases of malignant mesothelioma (MM) between 2000 and 2012 using the Hospital-Based Cancer Registry database in the state of S\u00e3o Paulo, Brazil. Methods: Possible cases were retrieved by assessing the database. Inclusion criteria were being older than 30 years of age and having ICD-O-3 topography and morphology codes related to MM. A board of expert pathologists reviewed the pathology reports and requested paraffin blocks in cases that demanded revision. After staining with calretinin, D2-40, WT-1 (as positive MM markers) and Ber-EP4 and MOC31 (as negative MM markers), cases were divided and studied independently by a pair of pathologists to confirm or discard the diagnosis of MM. Results: Our sample comprised 482 cases from 25 hospitals, and 130 needed further histological revision. We received 73 paraffin blocks with adequate material. After board analysis, there were 9 cases with a definitive diagnosis of MM, improving the diagnostic rate in 12%. Two cases of previously diagnosed MM were discarded by review. Conclusions: Our results confirm that part of MM underdiagnosis and underreporting in Brazil is due to incomplete or mistaken pathological diagnosis.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20230343","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T16:04:32Z","timestamp":1713974672000},"page":"e2023343","source":"Crossref","is-referenced-by-count":2,"title":["Identifying malignant mesothelioma by a pathological survey using the S\u00e3o Paulo state hospital cancer registry, Brazil"],"prefix":"10.36416","author":[{"given":"Fabiola","family":"Del Carlo Bernardi 1","sequence":"first","affiliation":[{"name":"1. Departamento de Ci\u00eancias Patol\u00f3gicas, Faculdade de Ci\u00eancias M\u00e9dicas da Santa Casa de S\u00e3o Paulo, S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Algranti2","sequence":"additional","affiliation":[{"name":"2. Diretoria de Pesquisa Aplicada, Funda\u00e7\u00e3o Jorge Duprat Figueiredo de Seguran\u00e7a e Medicina do Trabalho - FUNDACENTRO - S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Dolhnikoff3","sequence":"additional","affiliation":[{"name":"3. Departamento de Patologia, Universidade de S\u00e3o Paulo - USP - S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00f3vis","family":"Ant\u00f4nio Lopes Pinto4","sequence":"additional","affiliation":[{"name":"4. Departamento de Patologia, A.C. Camargo Cancer Center, S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivanir","family":"Martins de Oliveira5","sequence":"additional","affiliation":[{"name":"5. Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva - INCA - Rio de Janeiro (RJ) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Nei Aparecida Martins Coletta6","sequence":"additional","affiliation":[{"name":"6. Instituto de Assist\u00eancia ao Servidor P\u00fablico Estadual de S\u00e3o Paulo - IAMSPE - S\u00e3o Paulo (SP), Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Caetano Albino da Silva7","sequence":"additional","affiliation":[{"name":"7. Departamento de Patologia, Funda\u00e7\u00e3o Pio XII\/Hospital de C\u00e2ncer de Barretos, Barretos (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adauto","family":"Jos\u00e9 Ferreira Nunes8","sequence":"additional","affiliation":[{"name":"8. Laborat\u00f3rio de Patologia, Hospital Amaral Carvalho, Ja\u00fa (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donaldo","family":"Botelho Veneziano9","sequence":"additional","affiliation":[{"name":"9. Setor de Registro Hospitalar de C\u00e2ncer, Hospital Amaral Carvalho, Ja\u00fa (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Terra de Moraes Luizaga10","sequence":"additional","affiliation":[{"name":"10. Funda\u00e7\u00e3o Oncocentro de S\u00e3o Paulo, S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Luiz Lorenzi11","sequence":"additional","affiliation":[{"name":"11. Escrit\u00f3rio Avan\u00e7ado no Estado de Santa Catarina, Funda\u00e7\u00e3o Jorge Duprat Figueiredo de Seguran\u00e7a e Medicina do Trabalho - FUNDACENTRO - Florian\u00f3polis (SC) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Rodrigues Mendon\u00e7a e Silva12","sequence":"additional","affiliation":[{"name":"12. Setor de Registro Hospitalar de C\u00e2ncer, A.C. Camargo Cancer Center, S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thais","family":"Mauad3","sequence":"additional","affiliation":[{"name":"3. Departamento de Patologia, Universidade de S\u00e3o Paulo - USP - S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22288","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.            Karpathiou G, Stefanou D, Froudarakis ME. Pleural neoplastic pathology. Respir Med. 2015;109(8):931-943. https:\/\/doi.org\/10.1016\/j.rmed.2015.05.014","DOI":"10.1016\/j.rmed.2015.05.014"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.            Lacourt A, Gramond C, Rolland P, Ducamp S, Audignon S, Astoul P, et al. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma. Thorax. 2014;69(6):532-539. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-203744","DOI":"10.1136\/thoraxjnl-2013-203744"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.            Baur X, Frank AL, Soskolne CL, Oliver LC, Magnani C. Malignant mesothelioma: Ongoing controversies about its etiology in females. Am J Ind Med. 2021;64(7):543-550. https:\/\/doi.org\/10.1002\/ajim.23257","DOI":"10.1002\/ajim.23257"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.            van Gerwen M, Alpert N, Flores R, Taioli E. An overview of existing mesothelioma registries worldwide, and the need for a US Registry. Am J Ind Med. 2020;63(2):115-120. https:\/\/doi.org\/10.1002\/ajim.23069","DOI":"10.1002\/ajim.23069"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.            Marinaccio A, Binazzi A, Bonafede M, Di Marzio D, Scarselli A; Regional Operating Centres. Epidemiology of malignant mesothelioma in Italy: surveillance systems, territorial clusters and occupations involved. J Thorac Dis. 2018;10(Suppl 2):S221-S227. https:\/\/doi.org\/10.21037\/jtd.2017.12.146","DOI":"10.21037\/jtd.2017.12.146"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.            Walker-Bone K, Benke G, MacFarlane E, Klebe S, Takahashi K, Brims F, et al. Incidence and mortality from malignant mesothelioma 1982-2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry. Occup Environ Med. 2023;80(4):186-191. https:\/\/doi.org\/10.1136\/oemed-2022-108669","DOI":"10.1136\/oemed-2022-108669"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.            Algranti E, Santana VS, Campos F, Salvi L, Saito CA, Cavalcante F, et al. Analysis of Mortality from Asbestos-Related Diseases in Brazil Using Multiple Health Information Systems, 1996-2017. Saf Health Work. 2022;13(3):302-307. https:\/\/doi.org\/10.1016\/j.shaw.2022.04.006","DOI":"10.1016\/j.shaw.2022.04.006"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.            U.S. Geological Service (USGS) [homepage on the Internet] Reston (VA): USGS); c2022 [cited 2022 Jan 15]. Minerals Yearbook Area Reports - International. Available from: https:\/\/www.usgs.gov\/search?keywords=Minerals+Yearbook+Area+Reports","DOI":"10.3133\/mybviii"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.            Algranti E, Saito CA, Carneiro AP, Moreira B, Mendon\u00e7a EM, Bussacos MA. The next mesothelioma wave: mortality trends and forecast to 2030 in Brazil. Cancer Epidemiol. 2015;39(5):687-692. https:\/\/doi.org\/10.1016\/j.canep.2015.08.007","DOI":"10.1016\/j.canep.2015.08.007"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.          Park EK, Takahashi K, Hoshuyama T, Cheng TJ, Delgermaa V, Le GV, et al., Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011;119(4):514-518. https:\/\/doi.org\/10.1289\/ehp.1002845","DOI":"10.1289\/ehp.1002845"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.          Santana VS, Salvi L, Cavalcante F, Campos F, Algranti E. Underreporting of mesothelioma, asbestosis and pleural plaques in Brazil. Occup Med (Lond). 2021;71(4-5):223-230. https:\/\/doi.org\/10.1093\/occmed\/kqab073","DOI":"10.1093\/occmed\/kqab073"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.          Pedra F, Silva PO, Mattos IE, Castro HA. Mortality by mesothelioma in Brazil, 1980 to 2010. Rev Bras Cancerol. 2014;60(3):199-206. https:\/\/doi.org\/10.32635\/2176-9745.RBC.2014v60n3.464","DOI":"10.32635\/2176-9745.RBC.2014v60n3.464"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.          Brasil. Minist\u00e9rio da Sa\u00fade [homepage on the Internet]. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; c2022 [cited 2022 Jan 15]. Diretrizes brasileiras para o diagn\u00f3stico do mesotelioma maligno de pleura. Portaria Conjunta N\u00ba 18, de 23 de novembro de 2020. Available from: https:\/\/www.gov.br\/conitec\/pt-br\/midias\/protocolos\/resumidos\/20210716_diretrizes-brasileiras-para-diagnstico-do-mesotelioma-maligno-de-pleura_resumido.pdf","DOI":"10.1590\/s0102-311x1999000100022"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.          Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, et al. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?. J Thorac Oncol. 2022;17(2):200-213. https:\/\/doi.org\/10.1016\/j.jtho.2021.10.010","DOI":"10.1016\/j.jtho.2021.10.010"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.          Woolhouse I, Bishop L, Darlison L, De Fonseka D, Edey A, Edwards J, et al. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma. Thorax. 2018;73(Suppl 1):i1-i30. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211321","DOI":"10.1136\/thoraxjnl-2017-211321"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.          Beasley MB, Galateau-Salle F, Dacic S. Pleural mesothelioma classification update. Virchows Arch. 2021;478(1):59-72. https:\/\/doi.org\/10.1007\/s00428-021-03031-7","DOI":"10.1007\/s00428-021-03031-7"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.          Hung YP, Chirieac LR. Pathology of Malignant Pleural Mesothelioma. Thorac Surg Clin. 2020;30(4):367-382. https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.007","DOI":"10.1016\/j.thorsurg.2020.08.007"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.          Governo do Estado de S\u00e3o Paulo. Funda\u00e7\u00e3o Oncocentro de S\u00e3o Paulo (FOSP) [homepage on the Internet] S\u00e3o Paulo: FOSP; c1974-2021 [cited 2022 Jan 15]. Rede de Aten\u00e7\u00e3o Oncol\u00f3gica do Estado de S\u00e3o Paulo. Available from: https:\/\/fosp.saude.sp.gov.br\/fosp\/diretoria-adjunta-de-informacao-e-epidemiologia\/rede-de-atencao-oncologica-do-estado-de-sao-paulo\/","DOI":"10.29381\/0103-8559\/20213102171-80"},{"key":"ref18","unstructured":"19.          World Health Organization. International Classification of Diseases for Oncology (ICD-O-3), 3rd ed. Geneva: World Health Organization; 2013."},{"key":"ref19","unstructured":"20.          Sociedade Brasileira de Patologia (SBP) [homepage on the Internet]. S\u00e3o Paulo: SBP; [cited 2022 Jan 15]. Parecer 33. Consulta: Tempo exigido para Arquivar os Blocos de Parafina, os Laudos e as L\u00e2minas dos Exames Histopatol\u00f3gicos, Citol\u00f3gicos e Requisi\u00e7\u00f5es dos Exames. Available from: https:\/\/www.sbp.org.br\/pareceres\/parecer-33\/"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.          Kalinke LP, Kalinke MA, Sarquis LMM, Marcondes L, Halfeld T, Mensi C, et al. A proposal for the creation of a system to monitor cases of malignant mesothelioma in Curitiba, Paran\u00e1, Brazil [Article in Portuguese]. Cad Saude Publica. 2018;34(9):e00171917. https:\/\/doi.org\/10.1590\/0102-311x00171917","DOI":"10.1590\/0102-311x00171917"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.          Labr\u00e8che F, Case BW, Ostiguy G, Chalaoui J, Camus M, Siemiatycki J. Pleural mesothelioma surveillance: validity of cases from a tumour registry. Can Respir J. 2012;19(2):103-107. https:\/\/doi.org\/10.1155\/2012\/650935","DOI":"10.1155\/2012\/650935"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"1.            Karpathiou G, Stefanou D, Froudarakis ME. Pleural neoplastic pathology. Respir Med. 2015;109(8):931-943. https:\/\/doi.org\/10.1016\/j.rmed.2015.05.014","DOI":"10.1016\/j.rmed.2015.05.014"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"2.            Lacourt A, Gramond C, Rolland P, Ducamp S, Audignon S, Astoul P, et al. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma. Thorax. 2014;69(6):532-539. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-203744","DOI":"10.1136\/thoraxjnl-2013-203744"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"3.            Baur X, Frank AL, Soskolne CL, Oliver LC, Magnani C. Malignant mesothelioma: Ongoing controversies about its etiology in females. Am J Ind Med. 2021;64(7):543-550. https:\/\/doi.org\/10.1002\/ajim.23257","DOI":"10.1002\/ajim.23257"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"4.            van Gerwen M, Alpert N, Flores R, Taioli E. An overview of existing mesothelioma registries worldwide, and the need for a US Registry. Am J Ind Med. 2020;63(2):115-120. https:\/\/doi.org\/10.1002\/ajim.23069","DOI":"10.1002\/ajim.23069"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"5.            Marinaccio A, Binazzi A, Bonafede M, Di Marzio D, Scarselli A; Regional Operating Centres. Epidemiology of malignant mesothelioma in Italy: surveillance systems, territorial clusters and occupations involved. J Thorac Dis. 2018;10(Suppl 2):S221-S227. https:\/\/doi.org\/10.21037\/jtd.2017.12.146","DOI":"10.21037\/jtd.2017.12.146"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"6.            Walker-Bone K, Benke G, MacFarlane E, Klebe S, Takahashi K, Brims F, et al. Incidence and mortality from malignant mesothelioma 1982-2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry. Occup Environ Med. 2023;80(4):186-191. https:\/\/doi.org\/10.1136\/oemed-2022-108669","DOI":"10.1136\/oemed-2022-108669"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"7.            Algranti E, Santana VS, Campos F, Salvi L, Saito CA, Cavalcante F, et al. Analysis of Mortality from Asbestos-Related Diseases in Brazil Using Multiple Health Information Systems, 1996-2017. Saf Health Work. 2022;13(3):302-307. https:\/\/doi.org\/10.1016\/j.shaw.2022.04.006","DOI":"10.1016\/j.shaw.2022.04.006"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"8.            U.S. Geological Service (USGS) [homepage on the Internet] Reston (VA): USGS); c2022 [cited 2022 Jan 15]. Minerals Yearbook Area Reports - International. Available from: https:\/\/www.usgs.gov\/search?keywords=Minerals+Yearbook+Area+Reports","DOI":"10.3133\/mybviii"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"9.            Algranti E, Saito CA, Carneiro AP, Moreira B, Mendon\u00e7a EM, Bussacos MA. The next mesothelioma wave: mortality trends and forecast to 2030 in Brazil. Cancer Epidemiol. 2015;39(5):687-692. https:\/\/doi.org\/10.1016\/j.canep.2015.08.007","DOI":"10.1016\/j.canep.2015.08.007"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"10.          Park EK, Takahashi K, Hoshuyama T, Cheng TJ, Delgermaa V, Le GV, et al., Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011;119(4):514-518. https:\/\/doi.org\/10.1289\/ehp.1002845","DOI":"10.1289\/ehp.1002845"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"11.          Santana VS, Salvi L, Cavalcante F, Campos F, Algranti E. Underreporting of mesothelioma, asbestosis and pleural plaques in Brazil. Occup Med (Lond). 2021;71(4-5):223-230. https:\/\/doi.org\/10.1093\/occmed\/kqab073","DOI":"10.1093\/occmed\/kqab073"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"12.          Pedra F, Silva PO, Mattos IE, Castro HA. Mortality by mesothelioma in Brazil, 1980 to 2010. Rev Bras Cancerol. 2014;60(3):199-206. https:\/\/doi.org\/10.32635\/2176-9745.RBC.2014v60n3.464","DOI":"10.32635\/2176-9745.RBC.2014v60n3.464"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"13.          Brasil. Minist\u00e9rio da Sa\u00fade [homepage on the Internet]. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; c2022 [cited 2022 Jan 15]. Diretrizes brasileiras para o diagn\u00f3stico do mesotelioma maligno de pleura. Portaria Conjunta N\u00ba 18, de 23 de novembro de 2020. Available from: https:\/\/www.gov.br\/conitec\/pt-br\/midias\/protocolos\/resumidos\/20210716_diretrizes-brasileiras-para-diagnstico-do-mesotelioma-maligno-de-pleura_resumido.pdf","DOI":"10.1590\/s0102-311x1999000100022"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"14.          Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, et al. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?. J Thorac Oncol. 2022;17(2):200-213. https:\/\/doi.org\/10.1016\/j.jtho.2021.10.010","DOI":"10.1016\/j.jtho.2021.10.010"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"15.          Woolhouse I, Bishop L, Darlison L, De Fonseka D, Edey A, Edwards J, et al. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma. Thorax. 2018;73(Suppl 1):i1-i30. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211321","DOI":"10.1136\/thoraxjnl-2017-211321"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"16.          Beasley MB, Galateau-Salle F, Dacic S. Pleural mesothelioma classification update. Virchows Arch. 2021;478(1):59-72. https:\/\/doi.org\/10.1007\/s00428-021-03031-7","DOI":"10.1007\/s00428-021-03031-7"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"17.          Hung YP, Chirieac LR. Pathology of Malignant Pleural Mesothelioma. Thorac Surg Clin. 2020;30(4):367-382. https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.007","DOI":"10.1016\/j.thorsurg.2020.08.007"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"18.          Governo do Estado de S\u00e3o Paulo. Funda\u00e7\u00e3o Oncocentro de S\u00e3o Paulo (FOSP) [homepage on the Internet] S\u00e3o Paulo: FOSP; c1974-2021 [cited 2022 Jan 15]. Rede de Aten\u00e7\u00e3o Oncol\u00f3gica do Estado de S\u00e3o Paulo. Available from: https:\/\/fosp.saude.sp.gov.br\/fosp\/diretoria-adjunta-de-informacao-e-epidemiologia\/rede-de-atencao-oncologica-do-estado-de-sao-paulo\/","DOI":"10.29381\/0103-8559\/20213102171-80"},{"key":"ref40","unstructured":"19.          World Health Organization. International Classification of Diseases for Oncology (ICD-O-3), 3rd ed. Geneva: World Health Organization; 2013."},{"key":"ref41","unstructured":"20.          Sociedade Brasileira de Patologia (SBP) [homepage on the Internet]. S\u00e3o Paulo: SBP; [cited 2022 Jan 15]. Parecer 33. Consulta: Tempo exigido para Arquivar os Blocos de Parafina, os Laudos e as L\u00e2minas dos Exames Histopatol\u00f3gicos, Citol\u00f3gicos e Requisi\u00e7\u00f5es dos Exames. Available from: https:\/\/www.sbp.org.br\/pareceres\/parecer-33\/"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"21.          Kalinke LP, Kalinke MA, Sarquis LMM, Marcondes L, Halfeld T, Mensi C, et al. A proposal for the creation of a system to monitor cases of malignant mesothelioma in Curitiba, Paran\u00e1, Brazil [Article in Portuguese]. Cad Saude Publica. 2018;34(9):e00171917. https:\/\/doi.org\/10.1590\/0102-311x00171917","DOI":"10.1590\/0102-311x00171917"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"22.          Labr\u00e8che F, Case BW, Ostiguy G, Chalaoui J, Camus M, Siemiatycki J. Pleural mesothelioma surveillance: validity of cases from a tumour registry. Can Respir J. 2012;19(2):103-107. https:\/\/doi.org\/10.1155\/2012\/650935","DOI":"10.1155\/2012\/650935"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T16:04:51Z","timestamp":1713974691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jornaldepneumologia.com.br\/details\/3942\/en-US\/identifying-malignant-mesothelioma-by-a-pathological-survey-using-the-sao-paulo-state-hospital-cancer-registry--brazil"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":44,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20230343","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]}}}